Status:
NOT_YET_RECRUITING
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
Lead Sponsor:
Assiut University
Conditions:
Sudden Sensorineural Hearing Loss (SSNHL)
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
* To evaluate efficacy of intratympanic injection of dexamethasone and hyaluronic acid mixture as a treatment modality in cases of sudden sensorineural hearing loss (SSNHL). * To compare outcomes of i...
Detailed Description
Sudden sensory neural hearing loss (SSNHL) is defined as sensorineural hearing loss of at least 30 dB over 3 consecutive frequencies within 3 days. Different treatment modalities have been used in tre...
Eligibility Criteria
Inclusion
- Adult patients (aged 18 and over)
- Patients with sudden sensory neural hearing loss (SSNHL)
Exclusion
- Patients with middle or external ear pathology.
- Patient with history of traumatic skull base fracture.
- Patients with previous ear surgery.
- Patients with other neurological symptoms or signs (Other cranial nerves affection).
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06878599
Start Date
May 1 2025
End Date
October 1 2028
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Asyut Governorate, Egypt, 71111